Joseph K. Belanoff
2015
In 2015, Joseph K. Belanoff earned a total compensation of $1.9M as Chief Executive Officer and President at Corcept Therapeutics, a 224% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,255,685 |
|---|---|
| Salary | $597,670 |
| Total | $1,853,355 |
Belanoff received $1.3M in option awards, accounting for 68% of the total pay in 2015.
Belanoff also received $597.7K in salary.
Rankings
In 2015, Joseph K. Belanoff's compensation ranked 5,033rd out of 13,638 executives tracked by ExecPay. In other words, Belanoff earned more than 63.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,033 out of 13,638 | 63rd |
Division Manufacturing | 1,855 out of 5,190 | 64th |
Major group Chemicals And Allied Products | 664 out of 1,854 | 64th |
Industry group Drugs | 527 out of 1,528 | 66th |
Industry Pharmaceutical Preparations | 415 out of 1,182 | 65th |
Source: SEC filing on April 21, 2017.
Belanoff's colleagues
We found four more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2015.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019